Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 208.76 million compared to CNY 249.22 million a year ago. Revenue was CNY 208.76 million compared to CNY 249.22 million a year ago.

Net income was CNY 25.09 million compared to CNY 30.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.1082 compared to CNY 0.1334 a year ago. Diluted earnings per share from continuing operations was CNY 0.1021 compared to CNY 0.1252 a year ago.